FDA says Ozempic, Wegovy are not in short supply anymore, which could impact prices
The U.S. Food and Drug Administration said Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply. CBS News New York reporter Ali Bauman reports on whether the supply change could lead to consumers paying more.
The U.S. Food and Drug Administration is asking some of its recently fired scientists if they will come back to their jobs, ...
Some of the calls were made to former employees in the Center for Devices and Radiological Health, the office responsible for ...
United Natural Trading Inc. issued a recall for Wegmans organic dry roasted salted almonds in January because they were ...
A list with the file name "Prohibited words" has been circulating since at least last week in official work chats, according ...
The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...
ZB Importing LLC has issued a recall for six varieties of Ülker snack rolls, biscuits and wafers due to undeclared wheat, ...
The shakes have also made at least 38 people ill, with 37 hospitalizations, the FDA said. The affected brands that sold the ...
"Under the updated 'healthy' claim, nutrient-dense foods that are encouraged by the Dietary Guidelines — vegetables, fruits, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback